Kiromic BioPharma, Inc. (KRBP) Stock Analysis
DELISTED
What happened to Kiromic BioPharma, Inc. (KRBP) stock?
Kiromic BioPharma, Inc. (KRBP) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Kiromic BioPharma, Inc. (KRBP). Kiromic BioPharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company focused on developing Gamma Delta T cell therapies for solid tumors. Their lead product candidates, ALEXIS-ISO-1 and ALEXIS-PRO-1, target Isomesothelin and PD-L1, respectively.
Last analyzed: Mar 16, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
Kiromic BioPharma, Inc. (KRBP) Healthcare & Pipeline Overview
KRBP OTC Market Information
KRBP trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy KRBP shares?
No. KRBP stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for KRBP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KRBP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kiromic BioPharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.